{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:48:23Z","timestamp":1794023303010,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12957-015-0763-7","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T18:19:18Z","timestamp":1452190758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Tumour-induced osteomalacia: a literature review and a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Jolanta","family":"Dadoniene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Miglinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Miltiniene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatas","family":"Vajauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitrij","family":"Seinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petras","family":"Butenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kacergius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"issue":"3","key":"763_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/ar.2014.5.0100","volume":"5","author":"NL Deep","year":"2014","unstructured":"Deep NL, Cain RB, McCullough AE, Hoxworth JM, Lal D. Sinonasal phosphaturic mesenchymal tumor: case report and systematic review. Allergy Rhinol Provid RI. 2014;5(3):162\u20137.","journal-title":"Allergy Rhinol Provid RI"},{"issue":"10","key":"763_CR2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1056\/NEJMcps1305773","volume":"370","author":"O-PR Hamnvik","year":"2014","unstructured":"Hamnvik O-PR, Becker CB, Levy BD, Loscalzo J. Clinical problem-solving. Wasting away N Engl J Med. 2014;370(10):959\u201366.","journal-title":"Wasting away N Engl J Med"},{"issue":"1","key":"763_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1):1\u201330.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"763_CR4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.anl.2008.01.003","volume":"36","author":"N Uramoto","year":"2009","unstructured":"Uramoto N, Furukawa M, Yoshizaki T. Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue. Auris Nasus Larynx. 2009;36(1):104\u20135.","journal-title":"Auris Nasus Larynx"},{"issue":"11","key":"763_CR5","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","volume":"471","author":"CK Ledford","year":"2013","unstructured":"Ledford CK, Zelenski NA, Cardona DM, Brigman BE, Eward WC. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed? Clin Orthop. 2013;471(11):3618\u201325.","journal-title":"Clin Orthop"},{"key":"763_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12891-015-0496-3","volume":"16","author":"Z Sun","year":"2015","unstructured":"Sun Z, Jin J, Qiu G, Gao P, Liu Y. Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors. BMC Musculoskelet Disord. 2015;16:43.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"763_CR7","first-page":"33","volume":"16","author":"RA McCANCE","year":"1947","unstructured":"McCANCE RA. Osteomalacia with Looser\u2019s nodes (Milkman\u2019s syndrome) due to a raised resistance to vitamin D acquired about the age of 15\u00a0years. Q J Med. 1947;16(1):33\u201346.","journal-title":"Q J Med"},{"issue":"4","key":"763_CR8","first-page":"493","volume":"21","author":"S Casari","year":"2003","unstructured":"Casari S, Rossi V, Varenna M, Gasparini M, Parafioriti A, Failoni S, et al. A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan. Clin Exp Rheumatol. 2003;21(4):493\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"763_CR9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/rheumatology\/39.12.1415","volume":"39","author":"GP Clunie","year":"2000","unstructured":"Clunie GP, Fox PE, Stamp TC. Four cases of acquired hypophosphataemic (\u2018oncogenic\u2019) osteomalacia. Problems of diagnosis, treatment and long-term management. Rheumatol Oxf Engl. 2000;39(12):1415\u201321.","journal-title":"Rheumatol Oxf Engl"},{"issue":"12","key":"763_CR10","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/ard.2006.057943","volume":"65","author":"JK Dowman","year":"2006","unstructured":"Dowman JK, Khattak FH. Oncogenic hypophosphataemic osteomalacia mimicking bone metastases on isotope bone scan. Ann Rheum Dis. 2006;65(12):1664.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"763_CR11","first-page":"373","volume":"9","author":"C Fuentealba","year":"2003","unstructured":"Fuentealba C, Pinto D, Ballesteros F, Pacheco D, Boettiger O, Soto N, et al. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2003;9(6):373\u20139.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"1","key":"763_CR12","first-page":"31","volume":"15","author":"B Harbeck","year":"2009","unstructured":"Harbeck B, Sch\u00f6cklmann H, Seekamp A, Czech N, M\u00f6nig H. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2009;15(1):31\u20134.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"13","key":"763_CR13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","volume":"97","author":"H Wang","year":"2015","unstructured":"Wang H, Zhong D, Liu Y, Jiang Y, Qiu G, Weng X, et al. Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up. J Bone Joint Surg Am. 2015;97(13):1084\u201394.","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"763_CR14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc070347","volume":"357","author":"E Hesse","year":"2007","unstructured":"Hesse E, Rosenthal H, Bastian L. Radiofrequency ablation of a tumor causing oncogenic osteomalacia. N Engl J Med. 2007;357(4):422\u20134.","journal-title":"N Engl J Med"},{"key":"763_CR15","first-page":"554","volume":"14","author":"A Prader","year":"1959","unstructured":"Prader A, Illig R, Uehlinger E, Stalder G. Rickets following bone tumor. Helv Paediatr Acta. 1959;14:554\u201365.","journal-title":"Helv Paediatr Acta"},{"issue":"3","key":"763_CR16","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18(3):R53\u201377.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"763_CR17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jbmr.5650040407","volume":"4","author":"RA Meyer","year":"1989","unstructured":"Meyer RA, Meyer MH, Gray RW. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Miner Res Off J Am Soc Bone Miner Res. 1989;4(4):493\u2013500.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"5","key":"763_CR18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI115735","volume":"89","author":"T Nesbitt","year":"1992","unstructured":"Nesbitt T, Coffman TM, Griffiths R, Drezner MK. Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest. 1992;89(5):1453\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"763_CR19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/jcem-67-1-46","volume":"67","author":"A Miyauchi","year":"1988","unstructured":"Miyauchi A, Fukase M, Tsutsumi M, Fujita T. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. J Clin Endocrinol Metab. 1988;67(1):46\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"763_CR20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26(3):345\u20138.","journal-title":"Nat Genet"},{"issue":"2","key":"763_CR21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"KE White","year":"2001","unstructured":"White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, et al. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab. 2001;86(2):497\u2013500.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"763_CR22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"SM Jan de Beur","year":"2005","unstructured":"Jan de Beur SM. Tumor-induced osteomalacia. JAMA. 2005;294(10):1260\u20137.","journal-title":"JAMA"},{"issue":"3","key":"763_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","volume":"27","author":"KE White","year":"2006","unstructured":"White KE, Larsson TE, Econs MJ. The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev. 2006;27(3):221\u201341.","journal-title":"Endocr Rev"},{"issue":"1","key":"763_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","volume":"30","author":"TO Carpenter","year":"2012","unstructured":"Carpenter TO. The expanding family of hypophosphatemic syndromes. J Bone Miner Metab. 2012;30(1):1\u20139.","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"763_CR25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2004;19(3):429\u201335.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"1","key":"763_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-09-0597","volume":"162","author":"I Ramon","year":"2010","unstructured":"Ramon I, Kleynen P, Body J-J, Karmali R. Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol Eur Fed Endocr Soc. 2010;162(1):1\u201310.","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"issue":"6","key":"763_CR27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","volume":"18","author":"S Liu","year":"2007","unstructured":"Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol JASN. 2007;18(6):1637\u201347.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"11","key":"763_CR28","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A. 2001;98(11):6500\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"763_CR29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-07-0485","volume":"158","author":"FM Hannan","year":"2008","unstructured":"Hannan FM, Athanasou NA, Teh J, Gibbons CLMH, Shine B, Thakker RV. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol Eur Fed Endocr Soc. 2008;158(2):265\u201371.","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"issue":"11","key":"763_CR30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.5732\/cjc.011.10013","volume":"30","author":"F-K Hu","year":"2011","unstructured":"Hu F-K, Yuan F, Jiang C-Y, Lv D-W, Mao B-B, Zhang Q, et al. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature. Chin J Cancer. 2011;30(11):794\u2013804.","journal-title":"Chin J Cancer"},{"issue":"4-5","key":"763_CR31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/01913129109016242","volume":"15","author":"N Weidner","year":"1991","unstructured":"Weidner N. Review and update: oncogenic osteomalacia-rickets. Ultrastruct Pathol. 1991;15(4-5):317\u201333.","journal-title":"Ultrastruct Pathol"},{"issue":"3","key":"763_CR32","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2012-3473","volume":"98","author":"DE Leaf","year":"2013","unstructured":"Leaf DE, Pereira RC, Bazari H, J\u00fcppner H. Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma. J Clin Endocrinol Metab. 2013;98(3):887\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"763_CR33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","volume":"33","author":"M Duet","year":"2008","unstructured":"Duet M, Kerkeni S, Sfar R, Bazille C, Liot\u00e9 F, Orcel P. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia. Clin Nucl Med. 2008;33(11):752\u20136.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"763_CR34","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2010-0543","volume":"95","author":"G Haeusler","year":"2010","unstructured":"Haeusler G, Freilinger M, Dominkus M, Egerbacher M, Amann G, Kolb A, et al. Tumor-induced hypophosphatemic rickets in an adolescent boy\u2014clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue. J Clin Endocrinol Metab. 2010;95(10):4511\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"763_CR35","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","volume":"44","author":"M Houang","year":"2013","unstructured":"Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, et al. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol. 2013;44(12):2711\u20138.","journal-title":"Hum Pathol"},{"issue":"2","key":"763_CR36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002560000306","volume":"30","author":"A Ogose","year":"2001","unstructured":"Ogose A, Hotta T, Emura I, Hatano H, Inoue Y, Umezu H, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol. 2001;30(2):99\u2013103.","journal-title":"Skeletal Radiol"},{"issue":"9","key":"763_CR37","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Xia W, Xing X, Silva BC, Li M, Wang O, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res Off J Am Soc Bone Miner Res. 2012;27(9):1967\u201375.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"9","key":"763_CR38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/cup.12209","volume":"40","author":"KH Gardner","year":"2013","unstructured":"Gardner KH, Shon W, Folpe AL, Wieland CN, Tebben PJ, Baum CL. Tumor-induced osteomalacia resulting from primary cutaneous phosphaturic mesenchymal tumor: a case and review of the medical literature. J Cutan Pathol. 2013;40(9):780\u20134. quiz 779.","journal-title":"J Cutan Pathol"},{"issue":"4","key":"763_CR39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00402-008-0808-2","volume":"129","author":"R Seijas","year":"2009","unstructured":"Seijas R, Ares O, Sierra J, P\u00e9rez-Dominguez M. Oncogenic osteomalacia: two case reports with surprisingly different outcomes. Arch Orthop Trauma Surg. 2009;129(4):533\u20139.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"3","key":"763_CR40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/art.23278","volume":"58","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM, Urig EJ, Williams RC. Tumor-induced osteomalacia: lessons learned. Arthritis Rheum. 2008;58(3):773\u20137.","journal-title":"Arthritis Rheum"},{"key":"763_CR41","first-page":"729387","volume":"2014","author":"AH Hautmann","year":"2014","unstructured":"Hautmann AH, Schroeder J, Wild P, Hautmann MG, Huber E, Hoffstetter P, et al. Tumor-induced osteomalacia: increased level of FGF-23 in a patient with a phosphaturic mesenchymal tumor at the tibia expressing periostin. Case Rep Endocrinol. 2014;2014:729387.","journal-title":"Case Rep Endocrinol"},{"issue":"7","key":"763_CR42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2169\/internalmedicine.47.0761","volume":"47","author":"E Ogura","year":"2008","unstructured":"Ogura E, Kageyama K, Fukumoto S, Yagihashi N, Fukuda Y, Kikuchi T, et al. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23. Intern Med Tokyo Jpn. 2008;47(7):637\u201341.","journal-title":"Intern Med Tokyo Jpn"},{"issue":"26","key":"763_CR43","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"J Seufert","year":"2001","unstructured":"Seufert J, Ebert K, M\u00fcller J, Eulert J, Hendrich C, Werner E, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med. 2001;345(26):1883\u20138.","journal-title":"N Engl J Med"},{"issue":"12","key":"763_CR44","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2011-1757","volume":"96","author":"WH Chong","year":"2001","unstructured":"Chong WH, Yavuz S, Patel SM, Chen CC, Collins MT. The importance of whole body imaging in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2001;96(12):3599\u2013600.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"763_CR45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1445-5994.2003.00488.x","volume":"33","author":"AM Dissanayake","year":"2003","unstructured":"Dissanayake AM, Wilson JL, Holdaway IM, Reid IR. Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging. Intern Med J. 2003;33(12):615\u20136.","journal-title":"Intern Med J"},{"issue":"9308","key":"763_CR46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur SM, Streeten EA, Civelek AC, McCarthy EF, Uribe L, Marx SJ, et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet. 2002;359(9308):761\u20133.","journal-title":"Lancet"},{"issue":"1","key":"763_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00264-001-0318-0","volume":"26","author":"M Moran","year":"2002","unstructured":"Moran M, Paul A. Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia. Int Orthop. 2002;26(1):61\u20132.","journal-title":"Int Orthop"},{"issue":"3","key":"763_CR48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","volume":"36","author":"JL Dupond","year":"2005","unstructured":"Dupond JL, Mahammedi H, Pri\u00e9 D, Collin F, Gil H, Blagosklonov O, et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case. Bone. 2005;36(3):375\u20138.","journal-title":"Bone"},{"issue":"6","key":"763_CR49","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","volume":"26","author":"P Andreopoulou","year":"2011","unstructured":"Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM, et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res Off J Am Soc Bone Miner Res. 2011;26(6):1295\u2013302.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"2","key":"763_CR50","first-page":"177","volume":"17","author":"VS Jagtap","year":"2011","unstructured":"Jagtap VS, Sarathi V, Lila AR, Malhotra G, Sankhe SS, Bandgar T, et al. Tumor-induced osteomalacia: a single center experience. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2011;17(2):177\u201384.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"1","key":"763_CR51","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","volume":"40","author":"K Agrawal","year":"2015","unstructured":"Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, et al. Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2015;40(1):e6\u201310.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"763_CR52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","volume":"54","author":"Y Rhee","year":"2001","unstructured":"Rhee Y, Lee JD, Shin KH, Lee HC, Huh KB, Lim SK. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf). 2001;54(4):551\u20134.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"763_CR53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/RLU.0000000000000341","volume":"40","author":"NR Rodrigues","year":"2015","unstructured":"Rodrigues NR, Calich AL, Etchebehere M, Ichiki WA, Pereira FP, Amstalden EMI, et al. Whole-body (99m)Tc-octreotide scintigraphy with SPECT\/CT to detect occult tumor inducing paraneoplastic osteomalacia. Clin Nucl Med. 2015;40(1):54\u20137.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"763_CR54","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","volume":"34","author":"P Antunes","year":"2007","unstructured":"Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, et al. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging. 2007;34(7):982\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"763_CR55","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/jc.2006-2865","volume":"92","author":"A Khosravi","year":"2007","unstructured":"Khosravi A, Cutler CM, Kelly MH, Chang R, Royal RE, Sherry RM, et al. Determination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab. 2007;92(6):2374\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"763_CR56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.1992.tb02342.x","volume":"37","author":"JN Harvey","year":"1992","unstructured":"Harvey JN, Gray C, Belchetz PE. Oncogenous osteomalacia and malignancy. Clin Endocrinol (Oxf). 1992;37(4):379\u201382.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"22","key":"763_CR57","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJM200205303462215","volume":"346","author":"F Paglia","year":"2002","unstructured":"Paglia F, Dionisi S, Minisola S. Octreotide for tumor-induced osteomalacia. N Engl J Med. 2002;346(22):1748\u20139. author reply 1748\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"763_CR58","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","volume":"22","author":"JL Geller","year":"2007","unstructured":"Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT. Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res Off J Am Soc Bone Miner Res. 2007;22(6):931\u20137.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"11","key":"763_CR59","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","volume":"24","author":"Y Aono","year":"2009","unstructured":"Aono Y, Yamazaki Y, Yasutake J, Kawata T, Hasegawa H, Urakawa I, et al. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia. J Bone Miner Res Off J Am Soc Bone Miner Res. 2009;24(11):1879\u201388.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"4","key":"763_CR60","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","volume":"124","author":"TO Carpenter","year":"2014","unstructured":"Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest. 2014;124(4):1587\u201397.","journal-title":"J Clin Invest"},{"issue":"8","key":"763_CR61","first-page":"1217","volume":"24","author":"Y Kinoshita","year":"2014","unstructured":"Kinoshita Y, Fukumoto S. Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia. Clin Calcium. 2014;24(8):1217\u201322.","journal-title":"Clin Calcium"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-015-0763-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:16:11Z","timestamp":1498259771000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjso.com\/content\/14\/1\/4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/s12957-015-0763-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"4"}}